METHODS AND APPARATUS FOR DETERMINING RISK OF AUTISM SPECTRUM DISORDER
Aspects of the invention described herein relate to bacteria and metabolites, which may be used in diagnostics, therapeutics and/or dietary supplements so as to identify the risk to an individual of developing ASD or ASD-like disorders, as well as, to inhibit, treat, and/or prevent the onset of ASD and/or and ASD-like disorders.
1 - 92 . (canceled)
93 . A method for identifying a subject that is at risk of having a condition comprising one or more of autism spectrum disorder, anxiety, Parkinson's Disease, Rett Syndrome, Fragile X Syndrome, Tuberous Sclerosis, Multiple Sclerosis, Alzheimer's Disease, Cornelia de Lange Syndrome, stroke, psychiatric diseases, amyotrophic lateral sclerosis, Leukodystrophies including Alexander Syndrome, alpha-synucleinopathies including Lewy Body Dementia, incidental Lewy body disease, Lewy body variant of Alzheimer's disease, multiple system atrophy, pure autonomic failure, or any combination thereof, comprising detecting one or more binding targets from one or more of bacteria of the genus Bacteriodetes , bacteroidia, bacteroidales, bacteroidaceae, Paraprevotella , Paraprevotellaceae, pseudomonadaceae, desulfobacteraceae, pseudomonadales, Staphylococcus , staphylococcaceae, Christensenella , rikenellaceae, odonbacteraceae, Pseudoramibacter , eubacteraciaea, Holdemania, Ruminococcus , lactobacillales, enterococcaceae, Enterococcus, Coprococcus , eggerthela, sutterela, alcaligenaceae, rhodospirillales, clostridaceae, rhodospirillaceae, ruminococcaceae, parabacteroides , or eisenbergiela , or any combination thereof in a biological sample from said subject, wherein the absence of, or lower level than a neurotypical control of one or more of bacteria of the genus Bacteriodetes , bacteroidia, bacteroidales, bacteroidaceae, Paraprevotella , Paraprevotellaceae, pseudomonadaceae, desulfobacteraceae, pseudomonadales, Staphylococcus , staphylococcaceae, Christensenella , rikenellaceae, odonbacteraceae, Pseudoramibacter , eubacteraciaea, Holdemania, Ruminococcus, parabacteroides or wherein the presence of, or higher level than a neurotypical control of lactobacillales, enterococcaceae, Enterococcus, Coprococcus , eggerthela, sutterela, alcaligenaceae, rhodospirillales, clostridaceae, rhodospirillaceae, ruminococcaceae, or eisenbergiela , or any combination thereof, in said biological sample indicates increased risk of developing the condition.
94 . The method of claim 93 , wherein the binding targets comprise nucleic acids.
95 . The method of claim 94 , wherein the nucleic acids comprise 16S sequences.
96 . The method of claim 93 , wherein said detecting one or more binding targets comprises detecting a nucleic acid selected from the group consisting of SEQ ID NO: 1-20.
97 . The method of claim 93 , wherein nucleic acids of SEQ ID NOs: 1-20 are detected.
98 . The method of claim 93 , wherein the binding targets comprise antigens.
99 . The method of claim 93 , wherein the bacteria are selected from the group consisting of the bacteria of Table 1A.1, or two or more bacteria listed in Table 1A.1.
100 . The method of claim 93 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1A.2, or two or more bacteria listed in Table 1A.2.
101 . The method of claim 93 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1B.1, or two or more bacteria listed in Table 1B.1.
102 . The method of claim 93 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1B.2, or two or more bacteria listed in Table 1B.2.
103 . The method of claim 93 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Tables 1A.1 and 1B.1, or two or more bacteria listed in any of Tables 1A.1 and 1B.1.
104 . The method of claim 93 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1A.1-1A.2 and Tables 1B.1-1B.2, or two or more bacteria listed in any of Tables 1A.1-1A.2 and 1B.1-B.2.
105 . A method for identifying a subject that is at risk of having a condition comprising one or more of autism spectrum disorder, anxiety, Parkinson's Disease, Rett Syndrome, Fragile X Syndrome, Tuberous Sclerosis, Multiple Sclerosis, Alzheimer's Disease, Cornelia de Lange Syndrome, stroke, psychiatric diseases, amyotrophic lateral sclerosis, Leukodystrophies including Alexander Syndrome, alpha-synucleinopathies including Lewy Body Dementia, incidental Lewy body disease, Lewy body variant of Alzheimer's disease, multiple system atrophy, pure autonomic failure, or any combination thereof, comprising:
applying a biological sample to a diagnostic device; and
identifying said subject as being at risk of having the condition when an amount of one or more antigens from one or more of bacteria of the genus Bacteriodetes , bacteroidia, bacteroidales, bacteroidaceae, Paraprevotella , Paraprevotellaceae, pseudomonadaceae, desulfobacteraceae, pseudomonadales, Staphylococcus , staphylococcaceae, Christensenella , rikenellaceae, odonbacteraceae, Pseudoramibacter , eubacteraciaea, Holdemania, Ruminococcus , lactobacillales, enterococcaceae, Enterococcus, Coprococcus , eggerthela, sutterela, alcaligenaceae, rhodospirillales, clostridaceae, rhodospirillaceae, or ruminococcaceae, or any combination thereof captured on the diagnostic device is great than a control amount obtained from a healthy subject.
106 . The method of claim 105 , wherein detection of said one or more antigens from one or more antigens from one or more of bacteria of the genus Bacteriodetes , bacteroidia, bacteroidales, bacteroidaceae, Paraprevotella , Paraprevotellaceae, pseudomonadaceae, desulfobacteraceae, pseudomonadales, Staphylococcus , staphylococcaceae, Christensenella , rikenellaceae, odonbacteraceae, Pseudoramibacter , eubacteraciaea, Holdemania, Ruminococcus , lactobacillales, enterococcaceae, Enterococcus, Coprococcus , eggerthela, sutterela, alcaligenaceae, rhodospirillales, clostridaceae, rhodospirillaceae, or ruminococcaceae, or any combination thereof is by fluorescence resonance energy transfer or bioluminescence resonance energy transfer.
107 . The method of claim 105 , wherein the bacteria are selected from the group consisting of the bacteria of Table 1A.1, or two or more bacteria listed in Table 1A.1.
108 . The method of claim 105 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1A.2, or two or more bacteria listed in Table 1A.2.
109 . The method of claim 105 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1B.1, or two or more bacteria listed in Table 1B.1.
110 . The method of claim 105 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1B.2, or two or more bacteria listed in Table 1B.2.
111 . The method of claim 105 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Tables 1A.1 and 1B.1, or two or more bacteria listed in any of Tables 1A.1 and 1B.1.
112 . The method of claim 105 , wherein the bacteria are selected from the group consisting of at least one of the bacteria of Table 1A.1-1A.2 and Tables 1B.1-1B.2, or two or more bacteria listed in any of Tables 1A.1-1A.2 and 1B.1-B.2.